期刊文献+

高分辨率压缩感知TOF-MRA在烟雾病分期及出血相关血管评估中的临床价值 被引量:1

Clinical value of high-resolution compressed sensing TOF-MRA in assessing Suzuki classification and the dilatation of hemorrhage related vascular in patients with moyamoya disease
下载PDF
导出
摘要 目的 探讨高分辨率压缩感知(compressed sensing, CS)时间飞跃法磁共振血管造影(time-of-fight magnetic resonance angiography, TOF-MRA)在烟雾病(moyamoya disease, MMD)分期及出血相关血管评估中的应用价值。材料与方法 回顾性分析同时行CS TOF-MRA和CT血管成像(computed tomography angiography, CTA)的MMD患者资料21例,两次检查时间间隔不超过2周。CS TOF-MRA扫描时间5 min 4 s,重建体素大小0.4 mm×0.4 mm×0.4 mm。两名放射科医生分别在CS TOF-MRA和CTA上对Suzuki分期、烟雾状血管(moyamoya vessel, MMV)、脉络膜前动脉(anterior choroidal artery, AChA)及后交通动脉(posterior communicating artery, PComA)的显示能力进行评价,并以单侧大脑半球为单位对AChA、PComA有无扩张进行分级评估。采用配对样本Wilcoxon秩和检验,将CS TOF-MRA及CTA评估结果进行对比分析。结果 研究共纳入37个大脑半球(5例单侧MMD,16例双侧MMD)。CS TOF-MRA对Suzuki分期评价能力与CTA相当(Z=-1.000,P>0.05),对MMV、AChA及PComA的显示能力均优于CTA(P值均<0.05)。CS TOF-MRA对AChA、PComA扩张分级评估能力与CTA相当(P值均<0.05)。结论 在临床合理的扫描时间内,高分辨率CS TOF-MRA序列对MMD出血相关血管的显示优于CTA,Suzuki分期和血管扩张分级评估与之相当,可作为MMD患者随访复查优先选择的影像学检查方法,具有较高的临床应用价值。 Objective:To explore the applied value of high-resolution compressed sensing(CS)time-of-fight magnetic resonance angiography(TOF-MRA)in assessing Suzuki classification and the dilatation of hemorrhage related vascular in patients with moyamoya disease(MMD).Materials and Methods:A retrospective analysis of twenty-one receivers who underwent both CS TOF-MRA and computed tomography angiography(CTA)within 2 weeks.The scan time of CS TOF-MRA was 5 min 4 s,with a reconstructed resolution of 0.4 mm×0.4 mm×0.4 mm.Visualization of Suzuki classification,moyamoya vessel(MMV),anterior choroidal artery(AChA),and posterior communicating artery(PComA)were independently ranked by two neuroradiologists on CS TOF-MRA and CTA,respectively.The unilateral cerebral hemisphere as a unit,the dilatation of AChA and PComA were graded using both CS TOF-MRA and CTA.Wilcoxon rank sum test was used to compare the evaluation results of CS TOF-MRA and CTA.Results:The evaluation ability of Suzuki classification,CS TOF-MRA was equivalent to CTA(Z=-1.000,P>0.05).The MMV,AChA and PComA were better visualized on CS TOF-MRA than CTA(both P<0.05).Thirty-seven hemisphere were enrolled(5 cases of unilateral MMD and 16 cases of bilateral MMD),the dilatation of AChA and PComA,were comparable to CTA(both P<0.05).Conclusions:Within a clinically reasonable time,high-resolution CS TOF-MRA outperforms CTA for visualization of hemorrhage related vascular and is equivalent to CTA for Suzuki classification and the dilatation of hemorrhage related vascular in MMD patients.High-resolution CS TOF-MRA can be used as a priority imaging examination for follow-up review of MMD patients,and has well applied value in clinical practice.
作者 李青 苏春秋 武鹏飞 吴伟 鲁珊珊 LI Qing;SU Chunqiu;WU Pengfei;WU Wei;LU Shanshan(Department of Radiology,the First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China;Department of Neurosurgery,the First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China)
出处 《磁共振成像》 CAS CSCD 北大核心 2023年第4期29-33,共5页 Chinese Journal of Magnetic Resonance Imaging
基金 国家自然科学基金(编号:82171907)。
关键词 脑血管疾病 烟雾病 出血 高分辨率压缩感知技术 磁共振血管造影术 磁共振成像 cerebrovascular disorders moyamoya disease intracranial hemorrhage high-resolution compressed sensing magnetic resonance angiography magnetic resonance imaging
  • 相关文献

参考文献4

二级参考文献27

  • 1杨明琪,倪明,王硕,赵继宗.出血型Moyamoya病临床分析[J].首都医科大学学报,2007,28(4):528-531. 被引量:26
  • 2Kobayashi E,Saeki N,Oishi H. Long-term natural history of hemorrhagic moyamoya disease in 42 patients[J].Journal of Neurosurgery,2000,(06):976-980.
  • 3Hashimoto N,Tominaga T,Miyamoto S. Guidelines for diagnosis and treatment of moyamoya disease (Spontaneous Occlusion of the Circle of Willis)[J].Neurologia Medico-Chirurgica(Tokyo),2012,(05):245-266.
  • 4Morioka M,Hamada J,Kawano T. Angiographic dilatation and branch extension of the anterior choroidal and posterior communicating arteries are predictors of hemorrhage in adult moyamoya patients[J].Stroke,2003,(01):90-95.
  • 5Kobayashi E,Saeki N,Oishi H. Long-term natural history of hemorrhagic moyamoya disease in 42 patients[J].Journal of Neurosurgery,2000,(06):976-980.
  • 6Saeki N,Nakazaki S,Kubota M. Hemorrhagic type moyamoya disease[J].Clinical Neurology and Neurosurgery,1997,(Suppl 2):196-201.
  • 7Morioka M,Hamada J,Todaka T. High-risk age for rebleeding in patients with hemorrhagic moyamoya disease:long-term follow-up study[J].Neurosurgery,2003,(05):1049-1055.
  • 8Houkin K,Yoshimoto T,Kuroda S. Angiographic analysis of moyamoya disease--how does moyamoya disease progress[J].Neurologia Medico-Chirurgica(Tokyo),1996,(11):783-788.
  • 9Aoki N. Cerebrovascular bypass surgery for the treatment of Moyamoya disease:Unsatisfactory outcome in the patients presenting with intracranial hemorrhage[J].Surgical Neurology,1993,(05):372-377.
  • 10Ikezaki K,Fukui M,Inamura T. The current status of the treatment for hemorrhagic type moyamoya disease based on a 1995 nationwide survey in Japan[J].Clinical Neurology and Neurosurgery,1997,(Suppl 2):183-186.

共引文献14

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部